200 related articles for article (PubMed ID: 35296012)
1. Case Report: Toripalimab Combined With Anlotinib in a Patient With Metastatic Upper Tract Urothelial Carcinoma After Pembrolizumab Failure.
Zan N; Zhang X; Du L; Lin Z; Yu D; Liu J; Gou F
Front Oncol; 2022; 12():796407. PubMed ID: 35296012
[TBL] [Abstract][Full Text] [Related]
2. Intracranial complete response to toripalimab and anlotinib in a patient with recurrent brain metastases of small cell lung cancer after failure of second-line maintenance therapy: a case report.
Huang F; Tang J; Lou J; Wang Q; Ma K; Qiao R; Si J; Kang Y; Chen H; Mei J; Wang H; Liu Y; Miao L
Transl Cancer Res; 2022 Sep; 11(9):3337-3342. PubMed ID: 36237231
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation.
Cao JZ; Wu W; Pan JF; Wang HW; Jiang JH; Ma Q
Front Oncol; 2021; 11():643413. PubMed ID: 34109111
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Two Cases of Soft-Tissue Sarcomas: High TMB as a Potential Predictive Biomarker for Anlotinib Combined With Toripalimab Therapy.
Li Y; Liu Y; Qu Y; Chen X; Qu X; Ye Y; Du X; Cheng Y; Xu M; Zhang H
Front Immunol; 2022; 13():832593. PubMed ID: 35603147
[TBL] [Abstract][Full Text] [Related]
5. Combination anlotinib and toripalimab for an advanced biliary tract cancer patient with high Eastern Cooperative Oncology Group performance status: a case report.
Liu L; Chen B; Tang M; Guo Y; Hou J; Zhou W; Zhu X
Anticancer Drugs; 2024 May; ():. PubMed ID: 38728054
[TBL] [Abstract][Full Text] [Related]
6. Case Report: PD-L1-negative advanced bladder cancer effectively treated with anlotinib and tislelizumab: A report of two cases.
Li T; Hu W; Jin L; Yin X; Kang D; Piao L
Front Oncol; 2023; 13():1164368. PubMed ID: 37124509
[TBL] [Abstract][Full Text] [Related]
7. Combination toripalimab and bevacizumab for an elderly urothelial carcinoma patient with brain metastasis who failed rapidly after radiotherapy: a case report and literature review.
Qu F; Yan X; Yu W
Anticancer Drugs; 2023 Feb; 34(2):317-324. PubMed ID: 36730918
[TBL] [Abstract][Full Text] [Related]
8. Toripalimab combined with targeted therapy and chemotherapy achieves pathologic complete response in gastric carcinoma: A case report.
Liu R; Wang X; Ji Z; Deng T; Li HL; Zhang YH; Yang YC; Ge SH; Zhang L; Bai M; Ning T; Ba Y
World J Clin Cases; 2022 Jun; 10(18):6184-6191. PubMed ID: 35949814
[TBL] [Abstract][Full Text] [Related]
9. Possible abscopal effect in urothelial carcinoma of the upper urinary tract after treatment with immune checkpoint inhibitors.
Ishiyama Y; Takagi T; Yoshida K; Iizuka J; Kakuta Y; Okumi M; Ishida H; Tanabe K
IJU Case Rep; 2020 Jan; 3(1):25-27. PubMed ID: 32743462
[TBL] [Abstract][Full Text] [Related]
10. Favorable response to pembrolizumab in granulocyte colony-stimulating factor-producing upper urinary tract urothelial carcinoma.
Takeda H; Matsumoto R; Takakuwa E; Hori K; Moriguchi T; Yamada S; Kikuchi H; Osawa T; Abe T; Shinohara N
IJU Case Rep; 2022 Mar; 5(2):108-112. PubMed ID: 35252793
[TBL] [Abstract][Full Text] [Related]
11. Advanced thymic lymphoepithelioma-like carcinoma with bone marrow metastases treated by immunotherapy combined with antiangiogenesis therapy: a case report.
Li YJ; Li YW; Cui GH; Li SH; Deng YW; Lu D
Anticancer Drugs; 2022 Aug; 33(7):686-690. PubMed ID: 35324515
[TBL] [Abstract][Full Text] [Related]
12. A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer.
Zhou M; Jin Y; Zhu S; Xu C; Li L; Liu B; Shen J
Clin Transl Immunology; 2024; 13(1):e1483. PubMed ID: 38223257
[TBL] [Abstract][Full Text] [Related]
13. Complete Response With Immunotherapy: A Case of Metastatic Bladder Cancer.
Singh B; Kaur P; Gupta S; Guragai N; Maroules M
J Investig Med High Impact Case Rep; 2021; 9():23247096211035603. PubMed ID: 34308703
[TBL] [Abstract][Full Text] [Related]
14. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
[TBL] [Abstract][Full Text] [Related]
15. Anlotinib combined with chemotherapy and immunotherapy for advanced pulmonary sarcomatoid cancer: a case report and literature review.
Piao MN; Ma XT; Tankere P; Liam CK; Li JL; Wang JP
Ann Transl Med; 2022 Sep; 10(18):1030. PubMed ID: 36267791
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with toripalimab and anlotinib in advanced esophageal squamous cell carcinoma: A case report.
Chen SC; Ma DH; Zhong JJ
World J Clin Cases; 2023 Sep; 11(27):6579-6586. PubMed ID: 37900244
[TBL] [Abstract][Full Text] [Related]
17. Current status and future perspectives of immunotherapy against urothelial and kidney cancer.
Kobayashi T; Takeuchi A; Nishiyama H; Eto M
Jpn J Clin Oncol; 2021 Oct; 51(10):1481-1492. PubMed ID: 34389866
[TBL] [Abstract][Full Text] [Related]
18. Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report.
Ikarashi D; Kitano S; Ishida K; Nakatsura T; Shimodate H; Tsuyukubo T; Tamura D; Kato R; Sugai T; Obara W
Front Oncol; 2020; 10():564714. PubMed ID: 33072593
[TBL] [Abstract][Full Text] [Related]
19. Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project.
Rizzo A; Buti S; Giannatempo P; Salah S; Molina-Cerrillo J; Massari F; Kopp RM; Fiala O; Galli L; Myint ZW; Tural D; Soares A; Pichler R; Mennitto A; Abahssain H; Calabrò F; Monteiro FSM; Albano A; Mollica V; Giudice GC; Takeshita H; Santoni M;
Clin Exp Metastasis; 2024 Jun; ():. PubMed ID: 38850317
[TBL] [Abstract][Full Text] [Related]
20. Complete and enduring response in an elderly patient with repeated recurrent gingival squamous cell carcinoma treated by combined toripalimab and single agent chemotherapy: a case report.
Wu Q; Zhang S; Hua X; Yu H; Zhong Y
Ann Palliat Med; 2021 Jun; 10(6):6968-6973. PubMed ID: 33183019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
